BOSTON—Mark Baldry, Chief Commercial Officer of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), recently sold 29,159 shares of the ...

Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

This week is quickly becoming a sea change moment for Sonos as the company looks to undo the damage done to its reputation ...

About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his ...

Arvinas, Inc, announced that its chief commercial officer, John Northcott, is stepping down as of mid-January. 1 While the ...

Sands, M.D., Ph.D., president and chief executive officer of Nurix. “John’s experience commercializing the BTK inhibitor ibrutinib as well as his experience building commercial teams ahead of ...

(RTTNews) - Pacira BioSciences, Inc. (PCRX), a specialty pharmaceutical company, Tuesday announced that Brendan Teehan has been named Chief Commercial Officer and Krys Corbett has been named Chief ...

Datamaran, the market-leading ESG governance software provider, announces the appointment of Sebastian Hempstead as its first ...

IRN-BRU maker AG Barr has appointed Dino Labbate to the newly created role of chief commercial officer, with immediate effect ...

Nurix Therapeutics, Inc. has appointed John Northcott as its new chief commercial officer, bringing over 20 years of experience in biotechnology commercialization. His background includes ...